Skip to main content
Clinical Trials/NCT05774392
NCT05774392
Withdrawn
Not Applicable

An Observational Study of Patients With Chronic Kidney Disease

Target PharmaSolutions, Inc.0 sites500,000 target enrollmentApril 1, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Disease, Chronic
Sponsor
Target PharmaSolutions, Inc.
Enrollment
500000
Primary Endpoint
To characterize the natural history of disease in patients with CKD/ESKD.
Status
Withdrawn
Last Updated
4 months ago

Overview

Brief Summary

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Registry
clinicaltrials.gov
Start Date
April 1, 2025
End Date
April 7, 2025
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult\* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface

Exclusion Criteria

  • Manual removal (sponsor or site request)
  • No EHR interface encounter \> 3 years
  • Engaged Cohort
  • Inclusion Criteria:
  • Adult \* patients diagnosed and managed for CKD/ESKD invited to participate
  • Ability to provide written informed consent
  • Exclusion Criteria:
  • Patient expressed desire to withdraw consent to complete PROs
  • Failure to complete PROs within 24 weeks of initial invitation
  • Greater than 24 months lapse of survey completion after baseline surveys completed

Outcomes

Primary Outcomes

To characterize the natural history of disease in patients with CKD/ESKD.

Time Frame: 20 Years

To assess safety and effectiveness of CKD/ESKD treatments and treatments for complications of either condition

Time Frame: 20 Years

Secondary Outcomes

  • To evaluate provider management practices in the treatment of patients with CKD/ESKD(20 Years)
  • To select and evaluate quality of care measures for patients with CKD/ESKD(20 Years)
  • To evaluate longitudinal and patient reported outcomes in CKD/ESKD(20 Years)

Similar Trials